ESR1 and breast carcinoma: Thus, for the first time, we demonstrate that OCT4 is dependent on ERα expression to suppress proliferation in ERα‐positive breast cancer cells through the regulation of DNMT1/ISL1 and the inactivation of ERK signalling pathway.